SECOND OPINION: THE RELATIONSHIP BETWEEN BIG PHARMA’S PRICE-GOUGING AND BLOCKBUSTER SPENDING ON DIRECT-TO-CONSUMER ADVERTISING
Greater List Price Transparency Will Help Deter Big Pharma’s Egregious… Read More
Greater List Price Transparency Will Help Deter Big Pharma’s Egregious… Read More
KFF Survey Finds Americans Want White House Contenders Talking Rx Prices,… Read More
Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug… Read More
Another Blockbuster Quarter for Profits as Big Pharma Maintains… Read More
PhRMA Undercuts Own Rhetoric by Showing the Cancer Drug Pipeline is Growing… Read More
Commission Targets More Than 100 Patents on Brand Name Products Listed in the… Read More
Another Series of Strong Earnings Reports For Brand Name Giants Fueled by… Read More
Broad-based Coalition of Advocates, Including AARP and Patients for Affordable… Read More
New Analysis Finds Drug Companies Continue to Price-Gouge American Patients,… Read More
More Q3 Earnings From Big Pharma Giants Top Wall Street Expectations Following… Read More
Research Exposes How Big Pharma’s Self-Serving Kickbacks Increase Costs and… Read More
Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times… Read More